Nollmann, F. I., & Ruess, D. A. (2020). Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising? Biomedicines.
Citação norma ChicagoNollmann, Friederike Inga, and Dietrich Alexander Ruess. "Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?" Biomedicines 2020.
ציטוט MLANollmann, Friederike Inga, and Dietrich Alexander Ruess. "Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?" Biomedicines 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.